IDiyas

For the Inventor, By the Inventor

Xi'an, China

Liang Qi

USPTO Granted Patents = 15

Average Co-Inventor Count = 13.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Xi'an, CN (2020 - 2022)
  • Xi+3 an, CN (2023)

Company Filing History:

goldMedal13 out of 104 
 
Shaanxi University of Science and Technology
 patents
silverMedal2 out of 9 
 
Xi'an Taikomed Pharmaceutical Technology Co., Ltd.
 patents

Years Active: 2020-2023

where 'Filed Patents' based on already Granted Patents

15 patents (USPTO):
1. 11597714 - Pleuromulin lipoic acid ester with antibacterial activity and a method of preparing the same (2023-03-07),
2. 11512049 - Pleuromutilin 2-[(diphenylmethyl)thio] acetic acid ester with anti-drug resistant bacteria activity and a method of preparing the same (2022-11-29),
3. 11510905 - Pleuromutilin (E)-4-(1-imidazoylmethyl)cinnamic acid ester with anti-drug resistant bacteria activity and a method of preparing the same (2022-11-29),
4. 11401233 - Pleuromutilin salicylic acid ester with antibacterial activity and a method of preparing the same (2022-08-02),
5. 11306076 - Silibinin lipoic acid ester with hepatoprotective activity and a method of preparing the same (2022-04-19),
6. 11168049 - Pleuromulin tretinoin ester with antibacterial activity and a method of preparing the same (2021-11-09),
7. 11155514 - Pleuromulin acitretin ester with antibacterial activity and a method of preparing the same (2021-10-26),
8. 11117859 - Pleuromutilin hippuric acid ester with antibacterial activity and a method of preparing the same (2021-09-14),
9. 10995053 - Hydroxytyrosol ursolic acid ester with antioxidant activity and methods of preparing the same (2021-05-04),
10. 10947182 - Cinnamyl alcohol cassic acid ester with antibacterial activity and a method of preparing the same (2021-03-16),
11. 10941120 - 6-aminouracil cassic acid ester with antibacterial activity and a method of preparing the same (2021-03-09),
12. 10906863 - Hydroxytyrosol 4-methoxycinnamic acid ester with antibacterial activity and a method of preparing the same (2021-02-02),
13. 10766885 - Silibinin 3,3'-thiodipropionic acid ester with hepatoprotective activity and a method of preparing the same (2020-09-08),
14. 10738077 - Hydroxytyrosol ursodeoxycholic acid ester with antioxidant activity and a method of preparing the same (2020-08-11),
15. 10640450 - Hydroxytyrosol dihydrocaffeate having antioxidant activity and a method for preparing the same (2020-05-05),

Title: Innovations and Contributions of Inventor Liang Qi

Introduction

Liang Qi is a prominent inventor based in Xi'an, China. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds with antibacterial properties. With a total of 15 patents to his name, his work is recognized for addressing critical issues in drug resistance.

Latest Patents

Liang Qi's latest patents include a compound known as Pleuromulin lipoic acid ester, which exhibits antibacterial activity against drug-resistant bacteria. The patent details a method for preparing this compound, which is represented by a specific formula. Another notable patent is for Pleuromutilin (E)-4-(1-imidazoylmethyl)cinnamic acid ester, also aimed at combating drug-resistant bacteria. This patent similarly outlines a method for synthesizing the compound, showcasing his innovative approach to pharmaceutical development.

Career Highlights

Throughout his career, Liang Qi has been associated with reputable institutions such as Shaanxi University of Science and Technology and Xi'an Taikomed Pharmaceutical Technology Co., Ltd. His work in these organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Liang Qi has collaborated with notable colleagues, including Dan Yang and Han Li. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Liang Qi's innovative work in developing antibacterial compounds positions him as a key figure in the fight against drug-resistant bacteria. His contributions through patents and collaborations reflect his commitment to advancing pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…